Takeda
Phase III success for Takeda in lymphoma drug
August 1, 2016Manufacturing and Production, Research and Development Adcetris, Seattle Genetics, Takeda, lymphoma
Takeda Oncology and Seattle Generic have announced new Phase III data for trial drug, Adcetris (brentuximab vedotin), in patients with …
Takeda says its cancer drug Adcetris gets European backing in for hodgkin lymphoma
July 6, 2016Research and Development European Commission, Takeda, drug trial, lymphoma
Takeda Pharmaceutical (TSE: 4502) said the European Commission has extended the marketing authorization for its Adcetris (brentuximab vedotin) to treat …
Takeda begins world’s first norovirus vaccine field trial
June 22, 2016Research and Development Takeda, Vaccine, norovirus
Takeda Pharmaceuticals (TSE: 4502) has announced that the first patient has received a dosage of their norovirus vaccine candidate, TAK-214, …
Takeda appoints new chief financial officer
May 12, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe
Takeda Pharmaceuticals has named James Kehoe its new chief financial officer. He will begin the role on June 15 2016, …
Takeda secures $38 million grant to develop affordable polio vaccine
May 10, 2016Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio
Takeda Pharmaceuticals has received a $38 million grant from the Bill and Melinda Gates Foundation to develop a low-cost polio …
Takeda, Teva name Hiroshi Matsumori CEO of Japanese generic drug joint venture
April 4, 2016Business Services, Sales and Marketing CEO Appointment, Takeda, Teva, joint venture
Japanese drug firm Takeda (TYO: 4502) and Israel-based Teva (NYSE: TEVA) named Hiroshi Matsumori the chief executive for their newly-formed …
FDA issues CRL for Takeda/Lundbeck’s Brintellix
March 29, 2016Manufacturing and Production, Research and Development Lundbeck, Takeda, brintellix
Takeda and Lundbeck have received a complete response letter from the US Food and Drug Administration (FDA) for the supplemental …
Takeda presents long-term Entyvio data in CD and UC
March 21, 2016Manufacturing and Production, Research and Development Crohn's, Crohn's and Colitis, Entyvio, Takeda, ulcerative colitis
Japan’s Takeda has presented interim findings from the GEMINI Long-Term Safety (LTS) study of ulcerative colitis drug Entyvio (vedolizumab) at …
Lundbeck gets go-ahead for US and EU licence expansions
February 4, 2016Medical Communications, Sales and Marketing Abilify, EMA, FDA, Lundbeck, Otsuka, Takeda, aripiprazole, brintellix, vortioxetine
Lundbeck has earned two recommendations from regulatory committees of the FDA and the EMA, which both recommended the company’s drugs …
Takeda to bring UK salesforce in-house
January 15, 2016Medical Communications, Sales and Marketing Takeda, field sales, marketing, sales, sales reps, salesforce
Takeda UK is to bring all of its sales teams and support resources in-house and reintegrate its field salesforce into …
Takeda in myeloma research drive
January 14, 2016Medical Communications, Research and Development Ninlaro, Phase II, Takeda, Takeda oncology, eric low, ixazomib, multiple myeloma, myeloma
Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …
Takeda and enGene partner to develop gastro drugs
January 13, 2016Research and Development Takeda
Takeda is teaming up with Canadian biotech enGene to develop novel therapies for specialty gastrointestinal (GI) diseases, using enGene’s ‘gene …
Takeda and Enterome collaborate on new therapeutics for stomach disorders
January 6, 2016Research and Development Enterome, Takeda, gastrointestinal, inflammatory bowel syndrome, irritable bowel syndrome
Takeda and Enterome Bioscience have entered a drug discovery collaboration to research and develop potential new therapeutics for disorders including …
Takeda and Teva set out generics joint venture plan
January 4, 2016Sales and Marketing Takeda, Teva, generics, joint venture
Takeda and Teva have detailed plans for a new joint venture to create a new company to market off-patent generic …
AstraZeneca to acquire Takeda’s respiratory franchise
December 16, 2015Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory
AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
